Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy.
Baskan
Emel Bulbul
EB
Tunali
Sükran
S
Adim
Saduman Balaban
SB
Kiyici
Murat
M
Ali
Ridvan
R
D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D017239:Paclitaxel / Q000008:administration & dosage / Q000627:therapeutic use*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; D019253:Proto-Oncogene Proteins c-bcl-2; D017239:Paclitaxel